⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 17, 2023Movement DisordersOpen Access

Genetic Testing of HTT Modifiers for Huntington's Disease: Considerations for Clinical Guidelines

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

There is no data being shared.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goldman et al. (2023) studied this question.

synapsesocial.com/papers/6a7e7a3a3f6f9569bd4c516d https://doi.org/10.1002/mds.29650

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Detailed analysis of <i>HTT</i> repeat elements in human blood using targeted amplification-free long-read sequencingOriginal Research · 2018 · 92 citations
2Are polygenic risk scores ready for the cancer clinic?—a perspectiveOriginal Research · 2022 · 22 citations
3A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestryOriginal Research · 2022 · 21 citations
4Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeRisk Assessment · 2020 · 20 citations
5The Psychological Impact of Predictive Genetic Testing for Huntington′s Disease: A Systematic Review of the LiteratureSystematic Review · 2014 · 68 citations